Results of adjuvant radiotherapy treatment following pharynesophageal reconstruction with free jejunal flap in locally advanced hypopharyngeal cancer

Nguyen Van Dang, Nguyen Thi Thu Nhung

Main Article Content

Abstract

Hypopharyngeal cancer is a common head and neck cancer in Vietnam. The treatment strategy for locally advanced is surgery combined with adjuvant radiotherapy. Our study involved 24 patients with stage III and IV hypopharyngeal cancer who underwent surgery with jejunal free flap reconstruction and postoperative adjuvant radiotherapy or chemoradiotherapy. The results revealed that most patients were at stage IVA (87.5%), with an average adjuvant radiation dose of 63.33 ± 4.44Gy. Radiation doses to the jejunal flap were measured as Dmax: 68.83 ± 4.88Gy, Dmean: 62.91 ± 4.62Gy, and Dmin: 46.14 ± 10.94Gy. Acute side effects are mainly grade 1, 2 and can be controlled. The patient’s swallowing function at the time before and after radiotherapy 1-, 3-, 6-, and 12- months is similar, with an average of 10 - 11 scores accordingto QLQ-H&N35 scale. Three- year overall survival (OS) and disease-free survival (DFS) rates were 71.6% and 43.5%, respectively. This research shows that the treatment regimen has good tolerability, while ensuring the patient’s swallowing function and promising survival outcomes.

Article Details

References

1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
2. Henriques De Figueiredo B, Fortpied C, Menis J, et al. Long-term update of the 24954 EORTC phase III trial on larynx preservation. Eur J Cancer. 2016;65:109-112. doi:10.1016/j.ejca.2016.06.024
3. Lefebvre JL, Andry G, Chevalier D, et al. Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol. 2012;23(10):2708-2714. doi:10.1093/annonc/mds065
4. Petersen JF, Timmermans AJ, van Dijk BAC, et al. Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg. 2018;275(1):181-189. doi:10.1007/s00405-017-4766-6
5. Tsai YT, Chen WC, Chien CY, et al. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma. World J Surg Oncol. 2020;18(1):82. doi:10.1186/s12957-020-01866-z
6. Van BP, Tien HN, Van NH, et al. Total Pharyngo-Laryngo-Cervical-Esophagectomy with Jejunal Free Flap Reconstruction in a Developing Country: A Case Report from Vietnam. Am J Case Rep. 2022;23:e934974. doi:10.12659/AJCR.934974
7. Tokashiki K, Okamoto I, Okada T, et al. Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma-A Multicenter Retrospective Study. J Clin Med. 2022;11(5):1464. doi:10.3390/jcm11051464
8. Bradley PJ. Symptoms and Signs, Staging and Co-Morbidity of Hypopharyngeal Cancer. Adv Otorhinolaryngol. 2019;83:15-26. doi:10.1159/000492304
9. Pegan A, Rašić I, Košec A, et al. Type II hypopharyngeal defect reconstruction - a single institution experience. Acta Clin Croat. 2018;57(4):673. doi:10.20471/acc.2018.57.04.10
10. Tokashiki K, Okamoto I, Okada T, et al. Postoperative Complications of Jejunal and Skin Valve Reconstruction in Free Reconstructive Surgery for Hypopharyngeal Carcinoma. Anticancer Res. 2021;41(8):4033-4038. doi:10.21873/anticanres.15203
11. Lu Q, Liang Y, Tian S, et al. Radiation-Induced Intestinal Injury: Injury Mechanism and Potential Treatment Strategies. Toxics. 2023;11(12):1011. doi:10.3390/toxics11121011
12. Fan J, Lin B, Fan M, et al. Research progress on the mechanism of radiation enteritis. Front Oncol. 2022;12. doi:10.3389/fonc.2022.888962
13. Stanic S, Mayadev JS. Tolerance of the small bowel to therapeutic irradiation: a focus on late toxicity in patients receiving para-aortic nodal irradiation for gynecologic malignancies. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2013;23(4):592-597. doi:10.1097/IGC.0b013e318286aa68
14. Chan JYW, Chow VLY, Chan RCL, et al. Oncological outcome after free jejunal flap reconstruction for carcinoma of the hypopharynx. Eur Arch Otorhinolaryngol. 2012;269(7):1827-1832. doi:10.1007/s00405-011-1836-z
15. Chang LS, Wang H, Ahn HC, et al. The Impact of Postoperative Radiotherapy on Dietary Function of Head and Neck Cancer Patients after Pharyngoesophageal Reconstruction with Free Jejunal Flap. J Clin Med. 2022;11(10):2860. doi:10.3390/jcm11102860
16. Perez-Smith D, Wagels M, Theile DR. Jejunal free flap reconstruction of the pharyngolaryngectomy defect: 368 consecutive cases. J Plast Reconstr Aesthetic Surg JPRAS. 2013;66(1):9-15. doi:10.1016/j.bjps.2012.08.033
17. Sharp DA, Theile DR, Cook R, et al. Long-term functional speech and swallowing outcomes following pharyngolaryngectomy with free jejunal flap reconstruction. Ann Plast Surg. 2010;64(6):743-746. doi:10.1097/SAP.0b013e3181af3019
18. Janoray G, Pointreau Y, Garaud P, et al. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation. J Natl Cancer Inst. 2016;108(4):djv368. doi:10.1093/jnci/djv368